Preserving Patient Access to Home Infusion Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Preserving Patient Access to Home Infusion Act (H.R. 4104) was a legislative proposal introduced in the 118th Congress aimed at maintaining or improving patient access to home infusion therapies. The bill was referred to the House Subcommittee on Health but did not advance further and ultimately failed or expired. No official summary or full text is available, limiting detailed analysis of its specific provisions or mechanisms. The bill falls within the health policy area and appears to focus on regulatory or reimbursement aspects related to home infusion services.
H.R. 4104 sought to address patient access to home infusion treatments but did not progress beyond subcommittee referral and expired without enactment.
- The bill is titled 'Preserving Patient Access to Home Infusion Act' and relates to health policy.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
- The bill failed or expired without further legislative action or enactment.
['Patients requiring home infusion therapies', 'Healthcare providers and suppliers of home infusion services', 'Potentially Medicare or Medicaid programs if reimbursement policies were affected']
['Lack of available full text and official summary limits understanding of implementation details and cost implications.', 'Unclear authority or enforcement mechanisms due to missing bill text.', 'Potential tradeoffs between access, cost, and regulatory oversight cannot be assessed.']
The bill was introduced in the House and referred to the Subcommittee on Health during the 118th Congress but did not advance further. The absence of additional legislative actions or summary information suggests limited congressional movement or prioritization. The policy area aligns with ongoing discussions about healthcare access and home-based treatment options.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have influenced insurance reimbursement policies for home infusion, potentially affecting healthcare costs and provider practices.', 'Changes in access to home infusion therapies might impact hospital admissions or outpatient care utilization.', 'Regulatory adjustments could alter market dynamics for home infusion suppliers.']
The absence of full bill text and an official summary limits transparency and public oversight. Tracking such bills requires access to complete legislative documents to evaluate policy impacts, funding, and enforcement provisions. The bill's failure to advance suggests limited legislative support or prioritization, which is important context for stakeholders monitoring healthcare access legislation.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.